Haili Biotech corrects the performance forecast for 2025, with an expected net loss of 314 million yuan.

Haili Biology has released a correction notice for its 2025 annual performance forecast, with an expected net profit of approximately -314 million yuan for the year 2025 attributable to the owners of the parent company. The company had originally forecast a net profit of 11 million to 16 million yuan.